Primary prevention of haemophilus influenzae type b

Abstract

Routine immunisation of infants against Haemophilus influenzae type b (Hib) has the potential to prevent up to 1200 cases of serious infection and 60 deaths every year in the United Kingdom. Sara Hodgson reports the findings of a study in the Oxford region to determine the safety and immunogenicity of the Hib conjugate vaccine PRP-T when given to British infants in concurrence with primary immunisations, according to the accelerated schedule of two, three and four months of age.